Telix Pharmaceuticals TLX
$8.37 −$0.34 (-3.90%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.37 0.00%
Open$8.66
Prev close$8.71
Day range$8.37 – $8.70
Volume269.4K
Market cap$2.84B
P/E (TTM)86.3
Dividend yield–
Fundamentals
Latest reported quarter: ANNUAL, ended Dec 2025
Revenue$803.79M+55.6% YoY
Operating profit$18.05M-67.5% YoY
Net profit-$7.13M-121.2% YoY
Diluted EPS-$0.02-121.6% YoY
Free cash flow-$15.08M-1,487.3% YoY
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin53.7%
Operating margin5.3%
Net margin3.8%
Return on equity7.4%
Return on assets2.6%
Return on invested capital6.4%
Current ratio2.01
Liabilities / assets64.2%
Cash & investments$251.91M
Total debt$575.95M
Net cash (debt)-$324.04M
Where the revenue comes from
Quarter 2025/FY
By business line
By region
Balance sheet
| Line item | 2026 Q2 | 2025 ANNUAL | 2025 Q4 | 2025 Q2 | 2024 ANNUAL |
|---|---|---|---|---|---|
| Total Assets | $1.36B | $1.16B | $1.16B | $1.19B | $940.38M |
| Total Current Assets | $488.02M | $330.28M | $330.28M | $398.01M | $570.12M |
| Cash and Cash Equivalents & Short-Term Investments | $251.91M | $141.87M | $141.87M | $207.16M | $440.00M |
| -Cash and Cash Equivalents | $251.91M | $141.87M | $141.87M | $207.16M | $440.00M |
| Receivables | $170.39M | $138.37M | $138.37M | $129.52M | $99.65M |
| -Accounts Receivable | $163.56M | $129.20M | $129.20M | $123.63M | $86.93M |
| -Taxes Receivable | $6.83M | $7.88M | $7.88M | $5.89M | $10.96M |
| Inventory | $39.03M | $37.08M | $37.08M | $35.23M | $23.62M |
| Other Current Assets | $26.69M | – | – | $26.10M | – |
| Total Non-Current Assets | $873.83M | $833.71M | $833.71M | $791.94M | $370.26M |
| Net PPE | $129.63M | $115.61M | $115.61M | $74.18M | $33.65M |
| -Gross PPE | $129.63M | $133.53M | $133.53M | $85.11M | $40.53M |
| Investments and Advances | $40.41M | $3.68M | $3.68M | $4.06M | $3.77M |
| -Available for Sale Securities | $40.41M | – | – | – | – |
| Goodwill and Other Intangible Assets | $584.61M | $592.82M | $592.82M | $584.17M | $257.86M |
| -Goodwill | $197.51M | $198.99M | $198.99M | $185.81M | $66.59M |
| -Other Intangible Assets | $387.10M | $393.84M | $393.84M | $398.36M | $191.27M |
| Non-Current Deferred Assets | $85.30M | $59.35M | $59.35M | $75.77M | $28.92M |
| Other Non-Current Assets | $33.89M | $60.90M | $60.90M | $53.76M | $46.06M |
| Total Liabilities | $874.18M | $748.61M | $748.61M | $768.01M | $587.44M |
| Total Current Liabilities | $242.34M | $231.62M | $231.62M | $298.58M | $205.09M |
| Payables | $202.82M | $137.42M | $137.42M | $141.60M | $83.83M |
| -Total Tax Payable | $33.85M | $30.74M | $30.74M | $51.74M | $30.09M |
| -Other Payable | $168.97M | $17.86M | $17.86M | $38.17M | $4.06M |
| Short-Term Debt and Capital Lease Obligation | $15.42M | $18.66M | $18.66M | $21.06M | $13.31M |
| -Current Debt | $11.51M | $13.11M | $13.11M | $12.69M | $11.76M |
| -Current Capital Lease Obligation | $3.92M | $5.55M | $5.55M | $8.37M | $1.55M |
| Current Provisions | $520,000.00 | $562,000.00 | $562,000.00 | $896,000.00 | $576,000.00 |
| Current Deferred Liabilities | $390,000.00 | $11.47M | $11.47M | $4.40M | $6.97M |
| Other Current Liabilities | $2.90M | $11.54M | $11.54M | $72.28M | $53.22M |
| Total Non-Current Liabilities | $631.83M | $516.99M | $516.99M | $469.43M | $382.35M |
| Long Term Debt and Capital Lease Obligation | $564.44M | $448.45M | $448.45M | $397.19M | $346.85M |
| -Long Term Debt | $504.88M | $391.91M | $391.91M | $371.48M | $341.81M |
| -Long Term Capital Lease Obligation | $59.56M | $56.53M | $56.53M | $25.71M | $5.04M |
| Non-Current Liabilities | $8.56M | $9.18M | $9.18M | $9.33M | $8.53M |
| Non-Current Deferred Liabilities | $43.30M | $44.71M | $44.71M | $40.21M | $7.83M |
| Employee Benefits | $607,000.00 | $444,000.00 | $444,000.00 | $356,000.00 | $305,000.00 |
| Other Non-Current Liabilities | $14.93M | $14.21M | $14.21M | $22.35M | $18.83M |
| Total Equity | $487.68M | $415.38M | $415.38M | $421.94M | $352.94M |
| Stockholders' Equity | $487.68M | $415.38M | $415.38M | $421.94M | $352.94M |
| Capital Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Common Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $490.92M | $479.96M | $479.96M | $473.11M | $414.01M |
| Retained Earnings | -$110.90M | -$154.54M | -$154.54M | -$150.98M | -$152.91M |
| Gains/Losses Not Affecting Retained Earnings | -$13.24M | $89.95M | $89.95M | $99.81M | $91.84M |
| Other Equity Interests | $120.89M | – | – | – | – |
| -Other Receivables | – | $1.29M | $1.29M | – | $1.77M |
| Prepaid Assets | – | $12.96M | $12.96M | – | $6.84M |
| -Accumulated Depreciation | – | -$17.92M | -$17.92M | -$10.94M | -$6.88M |
| -Long Term Equity Investment | – | $3.68M | $3.68M | $4.06M | $3.77M |
| Non Current Accounts Receivables | – | $1.34M | $1.34M | – | – |
| -Accounts Payable | – | $88.81M | $88.81M | $51.69M | $49.68M |
| Current Accrued Expenses | – | $32.61M | $32.61M | $43.71M | $33.05M |
Income statement
| Line item | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL | 2021 ANNUAL |
|---|---|---|---|---|---|
| Total Revenue as Reported | $803.79M | $516.55M | $332.98M | $108.91M | – |
| Total Operating Revenue | $803.79M | $516.55M | $332.98M | $108.91M | $3.55M |
| Cost of Revenue | $377.36M | $180.39M | $123.45M | $44.34M | $1.85M |
| Gross Profit | $426.44M | $336.16M | $209.53M | $64.58M | $1.70M |
| Operating Expense | $408.39M | $280.58M | $174.57M | $115.05M | $73.32M |
| Selling and Admin Expenses | $237.15M | $152.19M | $89.38M | $59.47M | $29.58M |
| -Selling & Marketing Expense | $141.36M | $72.62M | $39.72M | $29.24M | $4.27M |
| -General & Admin Expense | $95.79M | $79.57M | $49.67M | $30.23M | $25.31M |
| Research & Development | $171.25M | $127.93M | $85.32M | $54.89M | $24.74M |
| Other Operating Expenses | -$12,000.00 | $458,000.00 | -$130,000.00 | $691,864.97 | $15.25M |
| Operating Profit | $18.05M | $55.58M | $34.97M | -$50.48M | -$71.62M |
| Net Non-Operating Interest Income (Expense) | -$35.04M | -$17.26M | -$8.41M | -$4.55M | -$3.78M |
| Non-Operating Interest Income | $5.83M | $7.18M | $671,000.00 | $680.30 | – |
| Non-Operating Interest Expense | $40.42M | $24.15M | $8.94M | $4.50M | $3.78M |
| Total Other Finance Costs | $452,000.00 | $292,000.00 | $142,000.00 | $56,464.89 | – |
| Other Income (Expense) | $11.72M | -$407,000.00 | -$23.96M | -$12.06M | $17.07M |
| Gain on Sale of Security | -$563,000.00 | $11.90M | -$734,000.00 | -$760,575.26 | $1.23M |
| Special Income (Charges) | $11.05M | -$12.60M | -$23.24M | -$11.37M | – |
| -Less:Restructuring and Mergern & Acquisition | -$11.62M | $13.08M | $22.69M | $11.37M | – |
| -Less:Impairment of Capital Assets | $566,000.00 | -$475,000.00 | $550,000.00 | $0.00 | – |
| Other Non-Operating Income (Expenses) | $1.23M | $299,000.00 | $14,000.00 | $61,907.29 | $15.84M |
| Pretax Profit | -$5.27M | $37.92M | $2.59M | -$67.09M | -$58.33M |
| Tax | $1.86M | $4.23M | -$1.61M | $3.71M | $32,620.99 |
| Net Profit | -$7.13M | $33.69M | $4.21M | -$70.80M | -$58.36M |
| Profit from Continuing Operations | -$7.13M | $33.69M | $4.21M | -$70.80M | -$58.36M |
| Net Income to Parent Company | -$7.13M | $33.69M | $4.21M | -$70.80M | -$58.36M |
| Net Income to Common Stockholders | -$7.13M | $33.69M | $4.21M | -$70.80M | -$58.36M |
| Basic EPS | -$0.02 | $0.10 | $0.01 | -$0.23 | -$0.21 |
| Diluted EPS | -$0.02 | $0.10 | $0.01 | -$0.23 | -$0.21 |
| Depreciation & Amortization & Depletion | – | – | – | – | $3.75M |
| -Depreciation & Amortization | – | – | – | – | $3.75M |
Cash flow
| Line item | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|
| Net cash flow from investing | -$285.92M | -$86.69M | -$16.84M | -$1.30M | -$13.61M |
| Net Cash Flow from Continuing Investing Activities | -$285.92M | -$86.69M | -$16.84M | -$1.30M | -$13.61M |
| Net PPE Purchase and Sale | -$25.69M | -$9.12M | -$6.31M | – | – |
| Net Intangibles Purchase and Sale | -$18.08M | -$13.07M | -$802,000.00 | – | – |
| Net Business Purchase and Sale | -$229.03M | -$23.20M | -$995,000.00 | – | – |
| Net Investment Purchase and Sale | -$892,000.00 | -$32.91M | -$8.70M | – | – |
| Net Other Investing Changes | -$12.22M | -$8.40M | -$37,000.00 | $15.51M | -$13.61M |
| Financing Cash Flow | -$3.72M | $416.79M | $7.09M | $1.85M | $2.21M |
| Net Cash Flow from Continuing Financing Activities | -$3.72M | $416.79M | $7.09M | $1.85M | $2.21M |
| Net Issuance Payments Of Debt | -$5.53M | $425.84M | $2.92M | $1.15M | $172,216.58 |
| Net Common Stock Issuance | $1.81M | $662,000.00 | $4.17M | $5,599.88 | $2.27M |
| Ending Cash Balance | $141.87M | $440.00M | $84.30M | $84.30M | $88.32M |
| Net Change in Cash | -$306.93M | $357.59M | $4.53M | -$7.42M | $2.33M |
| Beginning Cash Balance | $440.00M | $84.30M | $78.78M | $88.32M | $84.65M |
| Effect of Exchange Rate Changes | $8.80M | -$1.89M | $992,000.00 | -$631,848.14 | $1.34M |
| Free Cash Flow | -$61.07M | $5.31M | $7.16M | -$15.08M | $13.73M |
| Net Other Financing Charges | – | -$9.71M | – | – | -$233,263.50 |
No comments yet — be the first to weigh in on TLX.
Sign in to join the discussion.